GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hexima Ltd (ASX:HXL) » Definitions » Tax Provision

Hexima (ASX:HXL) Tax Provision : A$0.00 Mil (TTM As of Dec. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Hexima Tax Provision?

Hexima's tax provision for the six months ended in Dec. 2023 was A$0.00 Mil. Its tax provision for the trailing twelve months (TTM) ended in Dec. 2023 was A$0.00 Mil.


Hexima Tax Provision Historical Data

The historical data trend for Hexima's Tax Provision can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hexima Tax Provision Chart

Hexima Annual Data
Trend Jun08 Jun09 Jun10 Jun20 Jun21 Jun22 Jun23
Tax Provision
Get a 7-Day Free Trial - - - - -

Hexima Semi-Annual Data
Dec06 Dec07 Jun08 Dec08 Jun09 Dec09 Jun10 Dec10 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Tax Provision Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Hexima Tax Provision Calculation

Tax to be paid.

Tax Provision for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hexima (ASX:HXL) Business Description

Traded in Other Exchanges
N/A
Address
84-90 Hotham Street, Corporate One, Preston, VIC, AUS, 3072
Hexima Ltd is a biotechnology company. The company is engaged in the research and development of plant-derived proteins and peptides for applications as human therapeutics.

Hexima (ASX:HXL) Headlines

From GuruFocus

Hexcel Schedules First Quarter 2022 Earnings Release and Conference Call

By Business Wire Business Wire 04-01-2022

Hexcel Declares Quarterly Dividend

By Business Wire Business Wire 01-26-2022

Top 5 4th Quarter Trades of Bouvel Investment Partners, LLC

By GuruFocus Research GuruFocus Editor 01-19-2023

Hexcel Declares Quarterly Dividend

By Business Wire Business Wire 04-25-2022

Hexcel Reports 2023 Second Quarter Results

By Business Wire 07-24-2023